"Clinical Trials"

During the past decade, South Texas Accelerated Research Therapeutics Midwest conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "South Texas Accelerated Research Therapeutics Midwest" are "Endometrial Neoplasms" (2 trials), "HER2 Negative Breast Neoplasms" (2 trials), "Ovarian Neoplasms" (2 trials), "Adenoid Cystic Carcinoma" (1 trials) and "Appendiceal Adenocarcinoma" (1 trials). Many other conditions were trialed in "South Texas Accelerated Research Therapeutics Midwest" in a lesser frequency.

Most popular intervention types in "South Texas Accelerated Research Therapeutics Midwest" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Enoblituzumab" (1 trials), "MGA012" (1 trials), "MGD024" (1 trials), "Pembrolizumab" (1 trials) and "SGN-B7H4V" (1 trials). Other intervention names were less common.

The vast majority of trials in "South Texas Accelerated Research Therapeutics Midwest" are 4 trials for "All" genders.

Currently, there are NaN active trials in "South Texas Accelerated Research Therapeutics Midwest". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in South Texas Accelerated Research Therapeutics Midwest, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in South Texas Accelerated Research Therapeutics Midwest, 4 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".